{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T10:46:31Z","timestamp":1648982791571},"reference-count":17,"publisher":"Japan Society of Smooth Muscle Research","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Smooth Muscle Res","J. Smooth Muscle Res."],"published-print":{"date-parts":[[2005]]},"DOI":"10.1540\/jsmr.41.247","type":"journal-article","created":{"date-parts":[[2006,1,20]],"date-time":"2006-01-20T05:56:58Z","timestamp":1137736618000},"page":"247-256","source":"Crossref","is-referenced-by-count":0,"title":["Effects of different alpha-1 adrenoceptor blockers on proximal urethral function using in vivo isovolumetric pressure changes"],"prefix":"10.1540","volume":"41","author":[{"given":"Takanori","family":"Yamaguchi","sequence":"first","affiliation":[{"name":"Department of Urology, Fukuoka City Medical Center for Sick Children and Infectious diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Nagano","sequence":"additional","affiliation":[{"name":"Department of Urology, Miyazaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Osada","sequence":"additional","affiliation":[{"name":"Department of Urology, Miyazaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"435","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"AUA Practice Guideline Committee (2003). AUA guideline of management of benign prostatic hyperplasia. Chapter 1: Diagnosis and treatment recommendations. J. Urol. 170: 530-547.","DOI":"10.1097\/01.ju.0000078083.38675.79"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Andersson, K.E., Larsson, B. and Sjogren, C. (1984). Characterization of the alpha-adrenoceptors in the female rabbit urethra. Br. J. Pharmacol. 81: 298-300.","DOI":"10.1111\/j.1476-5381.1984.tb10078.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Caine, M., Pfau, A. and Perlberg, S. (1976). The use of alpha-adrenergic blockers in benign prostatic obstruction. Br. J. Urol. 48: 255-263.","DOI":"10.1111\/j.1464-410X.1976.tb10214.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chon, J.K., Borkowski, A., Partin, A.W., Isaacs J.T., Jacobs, S.C. and Kyprianou, N. (1999). &alpha;1-Adrenoceptor antagonists terazosin and doxazosin induced prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia. J. Urol. 161: 2002-2008.","DOI":"10.1016\/S0022-5347(05)68873-8"},{"key":"5","unstructured":"DeReijke, T.M. and Klarskov, P. (2000). Doxazosin versus alfuzosin in benign prostatic hyperplasia: results of a multinational, randomized, double-blind European trial. Eur. J. Urol. 37: 473-479."},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(94)90136-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Hayashi, M., Hanano, M. and Shintani, F. (1987). Relative bioavailability of prazosin hydrochloride tablet in man. Jpn. J. Clin. Pharmacol. 9: 385-394.","DOI":"10.3999\/jscpt.9.385"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Kunisawa, Y., Kawabe, K., Niijima, T., Honda, K. and Takenaka, T. (1985). A pharmacological study of alpha adrenergic receptor subtypes in smooth muscle of human urinary bladder base and prostatic urethra. J. Urol. 134: 396-398.","DOI":"10.1016\/S0022-5347(17)47185-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Lee, E. and Lee, C. (1997). Clinical comparison of selective and nonselective alpha 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses. Br. J. Urol. 80: 606-610.","DOI":"10.1046\/j.1464-410X.1997.00411.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Lepor, H., Tang, R., Kobayashi, S., Shapiro, E., Forray, C., Wetzel, J.M. and Gluchowski, C. (1995). Localization of the &alpha;1A-adrenoceptor in the human prostate. J. Urol. 154: 2096-2099.","DOI":"10.1016\/S0022-5347(01)66704-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Lepor, H. (1993). Medical therapy for benign prostatic hyperplasia. Urol. 42: 483-501.","DOI":"10.1016\/0090-4295(93)90258-C"},{"key":"12","unstructured":"Lomasney, J.W., Cotecchia, S. and Lefknowitz, R.J. (1987). Molecular biology &alpha;-adrenergic receptors; implications for receptor classification and structure-function relationship. Biochim. Biophys. Acta. 127: 1095-1099."},{"key":"13","doi-asserted-by":"crossref","unstructured":"Pool, J.L. and Kirby, R.S. (2001). Clinical significance of alpha 1-adrenoceptor selectivity in the management of benign prostatic hyperplasia. Int. Urol. Nephrol. 33: 407-412.","DOI":"10.1023\/A:1019504703485"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Price, D.T., Schwinn, D.A., Lomasney, J.W., Allen, L.F., Caron, M.G. and Lefkowitz, R.J. (1993). Identification, quantification, and localization of mRNA for three distinct alpha1 adrenergic receptor subtypes in human prostate. J. Urol. 150: 546-551.","DOI":"10.1016\/S0022-5347(17)35544-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Sullivan, J. and Abrams, P. (1999). Alpha-adrenoceptor antagonists in neurogenic lower urinary tract dysfunction. Urol. 53 (Suppl 3A): 21-28.","DOI":"10.1016\/S0090-4295(98)00535-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Thiyagarajan, M. (2002). Alpha-adrenoceptor antagonists in the treatment of benign prostate hyperplasia. Pharmacol. 65: 119-124.","DOI":"10.1159\/000058037"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Yamaguchi, T., Kitada, S. and Osada, Y. (1993). The role of adrenoceptors in the proximal urethral function of female and male rabbits using an <i>in vivo<\/i> model of isovolumetric urethral pressure generation. Neurourol. Urodyn. 12: 49-57.","DOI":"10.1002\/nau.1930120107"}],"container-title":["Journal of Smooth Muscle Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jsmr\/41\/5\/41_5_247\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T17:38:51Z","timestamp":1619026731000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jsmr\/41\/5\/41_5_247\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1540\/jsmr.41.247","relation":{},"ISSN":["0916-8737","1884-8796"],"issn-type":[{"value":"0916-8737","type":"print"},{"value":"1884-8796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}